Reducing cardiovascular events in high-risk patients: the challenge of managing hypertension in patients with diabetic renal disease [0.03%]
高危患者心血管事件的预防与管理——糖尿病肾病合并高血压患者的血压控制挑战
Robert D Toto
Robert D Toto
Hypertension is more prevalent and more difficult to control and is associated with a higher mortality rate in patients with diabetes than in nondiabetic patients. Elevated blood pressure contributes importantly to the development of albumi...
Cardiovascular morbidity and mortality in high-risk populations: epidemiology and opportunities for risk reduction [0.03%]
高危人群的心血管病发病率和死亡率：流行病学与降低风险的机会
Wanpen Vongpatanasin
Wanpen Vongpatanasin
Despite significant growth in the number of drug classes and individual agents available to combat various cardiovascular (CV) risk factors in clinical practice, the prevalence of these risk factors, including hypertension, diabetes mellitu...
Pathophysiology of target-organ disease: does angiotensin II remain the key? [0.03%]
靶器官疾病的病理生理学：血管紧张素II仍是关键因素吗？
Ronald G Victor
Ronald G Victor
Basic research provides an increasingly compelling rationale for renin-angiotensin system (RAS) blockade in hypertension treatment and cardiovascular risk reduction. Clinical trials addressing blood pressure-independent effects of angiotens...
Thomas G Pickering
Thomas G Pickering
Intracerebral hemorrhage: a life-threatening complication of hypertension during pregnancy [0.03%]
妊娠期高血压的致命并发症：脑出血
Xuming Dai,Joseph A Diamond
Xuming Dai
Intracerebral hemorrhage (ICH) is an infrequent but severe complication in pregnant women with hypertension. The authors describe a patient with chronic hypertension who developed superimposed preeclampsia and spontaneous ICH during the thi...
Hypertension control: still not there-how to select the right add-on therapy to reach goal blood pressures [0.03%]
高血压的控制仍未达标——如何选择联合治疗以达到目标血压值
Joel M Neutel,Domenic A Sica,Stanley S Franklin
Joel M Neutel
This expert panel discussion was held on August 17, 2007. The panel was moderated by Joel M. Neutel, MD, Orange County Research Center, Tustin, California. Participants included Domenic A. Sica, MD, Virginia Commonwealth University, Richmon...
Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patients [0.03%]
高血压高危患者心血管事件的一级预防治疗进展
Prakash Deedwania
Prakash Deedwania
The identification and treatment of high-risk patients for cardiovascular disease reduces the risk of morbidity and mortality. Significant risk factors for cardiovascular events in hypertensive patients over and above dyslipidemia, smoking,...
Angiotensin-converting enzyme inhibitors in the treatment of hypertension: an update [0.03%]
高血压治疗中血管紧张素转换酶抑制剂的更新展望
William B White
William B White
Angiotensin-converting enzyme inhibitors are an important treatment option for hypertension, especially when elevated blood pressure exists in the presence of diabetes mellitus, chronic kidney disease, or congestive heart failure. This arti...
The efficacy and tolerability of nebivolol in hypertensive African American patients [0.03%]
nebivolol治疗高血压非洲美国患者的疗效和耐受性
Elijah Saunders,William B Smith,Karen B DeSalvo et al.
Elijah Saunders et al.
Hypertensive African Americans often respond poorly to beta-blocker monotherapy, compared with whites. There is evidence, however, that suggests that this response may be different if beta-blockers with vasodilating effects are used. This 1...
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2007 Nov;9(11):866-75. DOI:10.1111/j.1524-6175.2007.07548.x 2007
Venous or arterial endothelium evaluation for early cardiovascular dysfunction in hypertensive patients? [0.03%]
高血压患者早期心血管功能障碍的内皮细胞评估：静脉还是动脉？
Marcelo Custódio Rubira,Fernanda Marciano Consolim-Colombo,Eneida Rejane Rabelo et al.
Marcelo Custódio Rubira et al.
Veins and arteries have active endothelium, producing vasoactive substances like nitric oxide. The aim of this study was to evaluate whether hypertensive patients exhibit venous endothelial dysfunction and to determine the relationship betw...